Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial

In this paper by Mohraz and colleagues (BMJ 2023;382:e070464, doi:10.1136/bmj.e070464, published 21 September 2023), the acceptance date on the PDF has been updated to match the correct html version on bmj.com (16 August 2023).

Source link

  • Share this post

Leave a Comment